Breakout Clearing Booster

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Breakout Clearing Booster
Generic name: SALICYLIC ACID
Manufacturer: Dermalogica, LLC.
Product type: HUMAN OTC DRUG
SPL set ID: 6ec73c30-a5cc-4937-aa7e-714f53ef2408
SPL ID: 13c79156-6209-47e4-ac7d-0ea27b1e5ce3
Version: 1
Effective date: 2025-12-18
Source export date: 2026-10-12
Source partition: 11
Source file: https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
Source manifest SHA-256: 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run: 20261013T011858Z
Imported at: 2026-10-13 02:43:11

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M006	openfda.application_number
brand name		Breakout Clearing Booster	openfda.brand_name
generic name		SALICYLIC ACID	openfda.generic_name
manufacturer name		Dermalogica, LLC.	openfda.manufacturer_name
ndc	package	68479-773-02	openfda.package_ndc
ndc	product	68479-773	openfda.product_ndc
ndc11	package	68479077302	derived:openfda.package_ndc
rxcui		251577	openfda.rxcui
spl id		13c79156-6209-47e4-ac7d-0ea27b1e5ce3	id
spl set id		6ec73c30-a5cc-4937-aa7e-714f53ef2408	set_id
unii		O414PZ4LPZ	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Do not use In or near eyes. If contact occurs, flush thoroughly with water. If irritation or redness develops, discontinue use. When using this product apply to affected areas only. skin irritation and dryness are more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.